Zietman AL - Search Results

1

Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma.

Paly JJ, Hallemeier CL, Biggs PJ, Niemierko A, Roeder F, Martínez-Monge R, Whitson J, Calvo FA, Fastner G, Sedlmayer F, Wong WW, Ellis RJ, Haddock MG, Choo R, Shipley WU, Zietman AL, Efstathiou JA. Paly JJ, et al. Among authors: zietman al. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):618-23. doi: 10.1016/j.ijrobp.2013.11.207. Epub 2014 Jan 8. Int J Radiat Oncol Biol Phys. 2014. PMID: 24411190

2

Radiation therapy in the management of early stage Hodgkin's disease presenting in later life.

Zietman AL, Linggood RM, Brookes AR, Convery K, Piro A. Zietman AL, et al. Cancer. 1991 Nov 1;68(9):1869-73. doi: 10.1002/1097-0142(19911101)68:9<1869::aid-cncr2820680903>3.0.co;2-h. Cancer. 1991. PMID: 1913538

3

Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report.

Suit HD, Zietman A, Tomkinson K, Ramsay J, Gerweck L, Sedlacek R. Suit HD, et al. Int J Radiat Oncol Biol Phys. 1990 Feb;18(2):365-73. doi: 10.1016/0360-3016(90)90102-p. Int J Radiat Oncol Biol Phys. 1990. PMID: 2154419

4

The response of two human tumor xenografts to fractionated irradiation. The derivation of alpha/beta ratios from growth delay, tumor control, and in vitro cell survival assays.

Zietman AL, Suit HD, Tomkinson KN, Thames HD, Sedlacek RS. Zietman AL, et al. Int J Radiat Oncol Biol Phys. 1990 Mar;18(3):569-75. doi: 10.1016/0360-3016(90)90062-o. Int J Radiat Oncol Biol Phys. 1990. PMID: 2318689

5

Fractionation sensitivity and immunological status in radiation treated murine sarcomas.

Miralbell R, Zietman A, Okunieff P, Thames HD, Suit HD. Miralbell R, et al. Int J Radiat Oncol Biol Phys. 1990 Apr;18(4):867-72. doi: 10.1016/0360-3016(90)90409-d. Int J Radiat Oncol Biol Phys. 1990. PMID: 2323974

6

The growth and cell kinetics of a secondary tumor after radiation or surgical treatment of the primary tumor.

Ramsay J, Zietman A, Preffer F, Suit HD. Ramsay J, et al. Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):809-13. doi: 10.1016/0360-3016(89)90071-0. Int J Radiat Oncol Biol Phys. 1989. PMID: 2777671

7

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome.

Zietman AL, Coen JJ, Shipley WU, Willett CG, Efird JT. Zietman AL, et al. J Urol. 1994 Mar;151(3):640-5. doi: 10.1016/s0022-5347(17)35036-x. J Urol. 1994. PMID: 7508522

8

The effect of pelvic radiation therapy on serum levels of prostate specific antigen.

Willett CG, Zietman AL, Shipley WU, Coen JJ. Willett CG, et al. Among authors: zietman al. J Urol. 1994 Jun;151(6):1579-81. doi: 10.1016/s0022-5347(17)35306-5. J Urol. 1994. PMID: 7514692

9

Re: The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients.

Zietman AL, Shipley WU. Zietman AL, et al. J Urol. 1994 Nov;152(5 Pt 1):1564-5; author reply 1565-6. J Urol. 1994. PMID: 7523713 No abstract available.

10

Radical prostatectomy and radical radiation therapy for clinical stages T1 to 2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen followup.

Zietman AL, Shipley WU, Coen JJ. Zietman AL, et al. J Urol. 1994 Nov;152(5 Pt 2):1806-12. doi: 10.1016/s0022-5347(17)32389-3. J Urol. 1994. PMID: 7523726 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page